Observational Program to Assess Respiratory Syncytial Virus (RSV) Hospitalization Rate in Population of Children at High-risk of Serious RSV Illness Who Received Palivizumab Immunoprophylaxis
Clinical trial NCT02282982 · COMPLETED
Trial details
- NCT number
- NCT02282982
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-10-01
- Primary completion
- 2015-05-01
- Enrollment
- 359
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.